A detailed history of Lilly Endowment Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Lilly Endowment Inc holds 98,898,810 shares of LLY stock, worth $76.2 Billion. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,898,810
Previous 99,768,810 0.87%
Holding current value
$76.2 Billion
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $515 Million - $689 Million
-870,000 Reduced 0.87%
98,898,810 $0
Q4 2023

Jan 25, 2024

SELL
$525.19 - $619.13 $113 Million - $133 Million
-215,000 Reduced 0.22%
99,768,810 $0
Q3 2023

Oct 12, 2023

SELL
$434.7 - $599.3 $454 Million - $626 Million
-1,045,000 Reduced 1.03%
99,983,810 $0
Q2 2023

Jul 10, 2023

SELL
$350.74 - $468.98 $531 Million - $711 Million
-1,515,000 Reduced 1.48%
101,028,810 $0
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $126 Million - $148 Million
-405,000 Reduced 0.39%
102,543,810 $0
Q4 2022

Jan 26, 2023

SELL
$321.55 - $374.67 $265 Million - $309 Million
-825,000 Reduced 0.79%
102,948,810 $0
Q3 2022

Oct 05, 2022

SELL
$296.48 - $337.87 $115 Million - $131 Million
-387,243 Reduced 0.37%
103,773,810 $33.6 Billion
Q2 2022

Jul 18, 2022

SELL
$278.73 - $327.27 $556 Million - $652 Million
-1,993,133 Reduced 1.88%
104,161,053 $33.8 Billion
Q1 2022

Apr 19, 2022

SELL
$234.69 - $291.66 $307 Million - $382 Million
-1,309,624 Reduced 1.22%
106,154,186 $30.4 Billion
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $176 Million - $219 Million
-784,800 Reduced 0.72%
107,463,810 $29.7 Billion
Q3 2021

Oct 08, 2021

SELL
$221.6 - $272.71 $255 Million - $314 Million
-1,150,592 Reduced 1.05%
108,248,610 $25 Billion
Q2 2021

Jul 19, 2021

SELL
$180.55 - $233.54 $163 Million - $211 Million
-902,898 Reduced 0.82%
109,399,202 $25.1 Billion
Q1 2021

Apr 12, 2021

SELL
$164.32 - $212.72 $136 Million - $177 Million
-830,243 Reduced 0.75%
110,302,100 $20.6 Billion
Q3 2020

Oct 05, 2020

SELL
$146.22 - $169.13 $62.6 Million - $72.4 Million
-427,961 Reduced 0.38%
111,132,343 $16.4 Billion
Q2 2020

Jul 16, 2020

SELL
$136.42 - $164.18 $233 Million - $281 Million
-1,711,038 Reduced 1.51%
111,560,304 $18.3 Billion
Q1 2020

Apr 10, 2020

SELL
$119.05 - $147.35 $153 Million - $190 Million
-1,289,257 Reduced 1.13%
113,271,342 $15.7 Billion
Q4 2019

Jan 13, 2020

SELL
$106.92 - $132.43 $218 Million - $270 Million
-2,039,705 Reduced 1.75%
114,560,599 $15.1 Billion
Q3 2019

Oct 08, 2019

SELL
$106.79 - $116.16 $22.4 Million - $24.4 Million
-210,000 Reduced 0.18%
116,600,304 $13 Billion
Q1 2019

Apr 16, 2019

SELL
$111.31 - $131.02 $134 Million - $158 Million
-1,205,000 Reduced 1.02%
116,810,304 $15.2 Billion
Q4 2018

Jan 14, 2019

SELL
$105.9 - $118.64 $147 Million - $164 Million
-1,385,500 Reduced 1.16%
118,015,304 $13.7 Billion
Q3 2018

Oct 09, 2018

SELL
$85.86 - $107.31 $228 Million - $284 Million
-2,650,000 Reduced 2.17%
119,400,804 $12.8 Billion
Q2 2018

Jul 12, 2018

SELL
$75.7 - $86.88 $77.6 Million - $89.1 Million
-1,025,000 Reduced 0.83%
122,050,804 $10.4 Billion
Q4 2017

Jan 17, 2018

SELL
$81.94 - $87.89 $33.2 Million - $35.6 Million
-405,000 Reduced 0.33%
123,075,804 $10.4 Billion
Q3 2017

Oct 10, 2017

BUY
$77.07 - $85.54 $9.52 Billion - $10.6 Billion
123,480,804
123,480,804 $10.6 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $732B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lilly Endowment Inc Portfolio

Follow Lilly Endowment Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lilly Endowment Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lilly Endowment Inc with notifications on news.